Ziegler Meditech Equity Partners
790 N Water St Suite 2275, Milwaukee, WI, 53202, United States
Overview
ZMEP is a limited partnership focusing on equity and equity-like investments in emerging medical device technologies. ZMEP invests globally drawing on the years of investing experience of its management team. With over 50 years of experience in medical device development and commercialization, the ZMEP management team has the ability to seek out and partner with leading entrepreneurs in the medical device field. With offices in the United States and Israel, ZMEP is positioned globally to partner with middle to late stage medical device companies showing great promise for success through commercialization.
- Total investments
- 2
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Health Care
- Venture Capital
- Wellness
Investment portfolio
- OrthoSensor
Participated · Series B · Oct 2013
OrthoSensor develops VERASENSE™, a disposable sensor-assisted instrument for total knee replacement that wirelessly delivers intraoperative data to guide ligament and implant positioning. The device enables surgeons to make evidence-based decisions on soft tissue balance and implant position in real time. The company is led by President and CEO Ivan Delevic. OrthoSensor raised new financing to support commercialization of VERASENSE and to expand product development activities. The funding round reflects the company’s effort to advance its core product toward broader market adoption. The company is based in Dania Beach, Florida. OrthoSensor develops and commercializes intelligent orthopaedic devices and data services. The company is led by President and CEO Jay Pierce and has developed the VERASENSE Knee System, an intelligent single-use device that provides surgeons with real-time, quantifiable data on implant placement, soft tissue balance and limb alignment. OrthoSensor closed a Series B-2 financing round that brought the total raised in the round to more than $48M. Series B investors included Dignity Health, Ziegler Meditech Equity Partners and undisclosed strategic and angel investors. The company intends to use the funds to grow the VERASENSE product line and to execute R&D, marketing and sales initiatives. OrthoSensor is based in Dania Beach, Florida. OrthoSensor develops and commercializes intelligent orthopedic devices across three product platforms: OrthoSensor Surgical, OrthoSensor Implantables and OrthoSensor Analytics. Its first product, the OrthoSensor™ Knee Balancer, is embedded with sensors that provide surgeons with actionable data on implant fit and knee kinematics to ensure proper soft tissue balance during total knee arthroplasty. The company plans to expand commercialization of the Knee Balancer and to launch a line of additional intelligent orthopedic devices. OrthoSensor closed an additional $15M in Series B financing, bringing the total Series B to $36M. The funding is intended to support commercialization and product launches. The company is led by CEO Jay Pierce and is based in Sunrise, Florida. OrthoSensor develops intelligent orthopedic devices and sensor-assisted surgery systems that provide surgeons with real-time, actionable information about implant placement and performance. Its technology targets knee, hip and shoulder replacement procedures as well as spinal and trauma applications. The company markets product lines named OrthoSensor Surgical, OrthoSensor Implantables and OrthoSensor Analytics. CEO Jay Pierce stated the company intends to use the new funding to move into the commercialization phase for these products. The company completed a $21M Series B financing to support that commercialization push. No operating metrics were disclosed in the article.
Team
No current team members are available.